In vitro formation of an inhibitory complex between an isosafrole metabolite and rat hepatic cytochrome P-450 PB-B
- PMID: 2571488
In vitro formation of an inhibitory complex between an isosafrole metabolite and rat hepatic cytochrome P-450 PB-B
Abstract
A series of in vitro studies was performed, in rat liver microsomes, in which metabolite intermediate (MI) complexation of cytochrome P-450 (P-450) by the methylenedioxyphenyl compound isosafrole was related to P-450 isozyme-specific inhibition of drug oxidation. The C19-steroid androst-4-ene-3,17-dione was selected for initial study because the stereoselective hydroxylation of this substrate is specific for certain P-450s. In control microsomes only the 6 beta- and 16 beta-hydroxylations of the steroid (catalyzed, respectively, by the P-450s PCN-E and PB-B) were inhibited by isosafrole (I50 = 100 and 110 microM). In contrast, the 7 alpha- and 16 alpha-hydroxylases (P-450 UT-F- and UT-A-mediated, respectively) were refractory to inhibition. After phenobarbital (PB) induction, steroid 6 beta- and 16 beta-hydroxylase activities were again inhibited (I50 = 170 and 190 microM) but, in addition, the 16 alpha-hydroxylase pathway was also inhibited (I50 = 200 microM). Spectral studies revealed that MI complexation of P-450 in untreated microsomes was minimal but was enhanced markedly after PB induction (up to 50% of the total P-450 content complexed). Thus, it is apparent that a PB-inducible P-450 is involved in MI complex formation under these conditions. Indeed the I50 of isosafrole toward steroid 16 beta-hydroxylase activity was decreased if the inhibitor was preincubated with NADPH-fortified PB-induced microsomes prior to substrate addition; the preincubation step did not enhance the inhibition of any other steroid hydroxylase pathway by isosafrole.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.Mol Pharmacol. 1989 May;35(5):736-43. Mol Pharmacol. 1989. PMID: 2725477
-
Selective reactivation of steroid hydroxylases following dissociation of the isosafrole metabolite complex with rat hepatic cytochrome P-450.Arch Biochem Biophys. 1986 Dec;251(2):471-8. doi: 10.1016/0003-9861(86)90354-1. Arch Biochem Biophys. 1986. PMID: 3800378
-
Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.Cancer Res. 1990 Feb 1;50(3):464-71. Cancer Res. 1990. PMID: 2105156
-
Safrole: its metabolism, carcinogenicity and interactions with cytochrome P-450.Food Cosmet Toxicol. 1981 Oct;19(5):657-66. doi: 10.1016/0015-6264(81)90518-6. Food Cosmet Toxicol. 1981. PMID: 7030889 Review. No abstract available.
-
Inhibitors of Cytochrome P-450s and their mechanism of action.Drug Metab Rev. 1981;12(1):1-117. doi: 10.3109/03602538109011082. Drug Metab Rev. 1981. PMID: 7028434 Review. No abstract available.
Cited by
-
Kinetic mechanism of time-dependent inhibition of CYP2D6 by 3,4-methylenedioxymethamphetamine (MDMA): Functional heterogeneity of the enzyme and the reversibility of its inactivation.Biochem Pharmacol. 2018 Oct;156:86-98. doi: 10.1016/j.bcp.2018.08.010. Epub 2018 Aug 13. Biochem Pharmacol. 2018. PMID: 30114388 Free PMC article.
-
Toxicity of kava kava.J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008 Jan-Mar;26(1):89-112. doi: 10.1080/10590500801907407. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008. PMID: 18322868 Free PMC article. Review.
-
Herbal bioactivation: the good, the bad and the ugly.Life Sci. 2004 Jan 9;74(8):935-68. doi: 10.1016/j.lfs.2003.09.035. Life Sci. 2004. PMID: 14672753 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources